Suchergebnis | Hamburg Open Science

Facetten

46 Einträge gefunden

Upregulation of the transcription factor TFAP2D is associated with aggressive tumor phenotype in prostate cancer lacking the TMPRSS2:ERG fusion
2020 - Forschungsinformationssystem des UKE
Upregulation of PTTG1 is associated with poor prognosis in prostate cancer
2020 - Forschungsinformationssystem des UKE
Expression of CCCTC-binding factor (CTCF) is linked to poor prognosis in prostate cancer
2020 - Forschungsinformationssystem des UKE
Up regulation of the Hippo signalling effector YAP1 is linked to early biochemical recurrence in prostate cancers
2020 - Forschungsinformationssystem des UKE
Claudin-1 upregulation is associated with favorable tumor features and a reduced risk for biochemical recurrence in ERG-positive prostate cancer
2020 - Forschungsinformationssystem des UKE
Upregulation of Phosphatase 1 Nuclear-Targeting Subunit (PNUTS) Is an Independent Predictor of Poor Prognosis in Prostate Cancer
2020 - Forschungsinformationssystem des UKE
Loss of CCAAT-enhancer-binding protein alpha (CEBPA) is linked to poor prognosis in PTEN deleted and TMPRSS2:ERG fusion type prostate cancers
2019 - Forschungsinformationssystem des UKE
Up regulation of Rho-associated coiled-coil containing kinase1 (ROCK1) is associated with genetic instability and poor prognosis in prostate cancer
2019 - Forschungsinformationssystem des UKE
Nuclear up regulation of the BRCA1-associated ubiquitinase BAP1 is associated with tumor aggressiveness in prostate cancers lacking the TMPRSS2:ERG fusion
2019 - Forschungsinformationssystem des UKE
High-level expression of protein tyrosine phosphatase non-receptor 12 is a strong and independent predictor of poor prognosis in prostate cancer
2019 - Forschungsinformationssystem des UKE - frei zugänglich
A nuclear shift of GSK3β protein is an independent prognostic factor in prostate cancer
2019 - Forschungsinformationssystem des UKE
Loss of PSP94 expression is associated with early PSA recurrence and deteriorates outcome of PTEN deleted prostate cancers
2019 - Forschungsinformationssystem des UKE - frei zugänglich
Down-Regulation of S100A8 is an Independent Predictor of PSA Recurrence in Prostate Cancer Treated by Radical Prostatectomy
2019 - Forschungsinformationssystem des UKE - frei zugänglich
Deletion of 3p13 is a late event linked to progression of TMPRSS2:ERG fusion prostate cancer
2018 - Forschungsinformationssystem des UKE - frei zugänglich
High BCAR1 expression is associated with early PSA recurrence in ERG negative prostate cancer
2018 - Forschungsinformationssystem des UKE - frei zugänglich
Deletion of 8p is an independent prognostic parameter in prostate cancer
2017 - Forschungsinformationssystem des UKE
High concordance of findings obtained from transgluteal magnetic resonance imaging - and transrectal ultrasonography-guided biopsy as compared with prostatectomy specimens
2017 - Forschungsinformationssystem des UKE
Up-regulation of mismatch repair genes MSH6, PMS2 and MLH1 parallels development of genetic instability, and is linked to tumor aggressiveness and early PSA recurrence in prostate cancer
2017 - Forschungsinformationssystem des UKE
FOXA1 expression is a strong independent predictor of early PSA recurrence in ERG negative prostate cancers treated by radical prostatectomy
2017 - Forschungsinformationssystem des UKE
βIII-tubulin overexpression is linked to agressive tumor features and genetic instability in urinary bladder cancer
2017 - Forschungsinformationssystem des UKE

Aktive Facetten

Facetten

Zugriff

Einrichtung

Medientyp

Karte

Erscheinungsjahr

Autor/in

Sprache

Upregulation of the transcription factor TFAP2D is associated with aggressive tumor phenotype in prostate cancer lacking the TMPRSS2:ERG fusion

Upregulation of PTTG1 is associated with poor prognosis in prostate cancer

Expression of CCCTC-binding factor (CTCF) is linked to poor prognosis in prostate cancer

Up regulation of the Hippo signalling effector YAP1 is linked to early biochemical recurrence in prostate cancers

Claudin-1 upregulation is associated with favorable tumor features and a reduced risk for biochemical recurrence in ERG-positive prostate cancer

Upregulation of Phosphatase 1 Nuclear-Targeting Subunit (PNUTS) Is an Independent Predictor of Poor Prognosis in Prostate Cancer

Loss of CCAAT-enhancer-binding protein alpha (CEBPA) is linked to poor prognosis in PTEN deleted and TMPRSS2:ERG fusion type prostate cancers

Up regulation of Rho-associated coiled-coil containing kinase1 (ROCK1) is associated with genetic instability and poor prognosis in prostate cancer

Nuclear up regulation of the BRCA1-associated ubiquitinase BAP1 is associated with tumor aggressiveness in prostate cancers lacking the TMPRSS2:ERG fusion

High-level expression of protein tyrosine phosphatase non-receptor 12 is a strong and independent predictor of poor prognosis in prostate cancer

A nuclear shift of GSK3β protein is an independent prognostic factor in prostate cancer

Loss of PSP94 expression is associated with early PSA recurrence and deteriorates outcome of PTEN deleted prostate cancers

Down-Regulation of S100A8 is an Independent Predictor of PSA Recurrence in Prostate Cancer Treated by Radical Prostatectomy

Deletion of 3p13 is a late event linked to progression of TMPRSS2:ERG fusion prostate cancer

High BCAR1 expression is associated with early PSA recurrence in ERG negative prostate cancer

Deletion of 8p is an independent prognostic parameter in prostate cancer

High concordance of findings obtained from transgluteal magnetic resonance imaging - and transrectal ultrasonography-guided biopsy as compared with prostatectomy specimens

Up-regulation of mismatch repair genes MSH6, PMS2 and MLH1 parallels development of genetic instability, and is linked to tumor aggressiveness and early PSA recurrence in prostate cancer

FOXA1 expression is a strong independent predictor of early PSA recurrence in ERG negative prostate cancers treated by radical prostatectomy

βIII-tubulin overexpression is linked to agressive tumor features and genetic instability in urinary bladder cancer